Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
<h4>Purpose</h4>To evaluate systemic adverse events after screening for retinopathy of prematurity (ROP) performed with mydriatic.<h4>Methods</h4>This was a retrospective case series study. Medical records of consecutive patients who underwent screening for ROP with 0.5% phen...
Guardado en:
Autores principales: | Shumpei Obata, Taku Imamura, Masashi Kakinoki, Takahide Yanagi, Yoshihiro Maruo, Masahito Ohji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63249ec9cc314c6399bf23de97ee17a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata S, et al.
Publicado: (2019) -
Two-field non-mydriatic fundus photography for diabetic retinopathy screening: a protocol for a systematic review and meta-analysis
por: Qi Li, et al.
Publicado: (2021) -
Effect of internal limiting membrane peeling on postoperative visual acuity in macula-off rhegmatogenous retinal detachment.
por: Shumpei Obata, et al.
Publicado: (2021) -
Metabolism in Retinopathy of Prematurity
por: Yohei Tomita, et al.
Publicado: (2021) -
Efficacy of WINROP as a Screening Tool for Retinopathy of Prematurity in the East Coast of Malaysia
por: Lim ZD, et al.
Publicado: (2020)